Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final option to the active ingredient Rotigotin (ATC code according to WHO: N04BC09)
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Imatinib (ATC code according to WHO: L01XE01)
Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final option to the active ingredient Cinacalcet (ATC code according to WHO: H05BX01)
Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final option to the active ingredient Infliximab (ATC code according to WHO: L04AB02)